Status:
COMPLETED
Reduction of Asthma Exacerbation Rate in Children by Non-invasive Monitoring of Inflammatory Markers in Exhaled Breath (Condensate): the RASTER Study
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
Conditions:
Asthma
Children
Eligibility:
All Genders
6-17 years
Brief Summary
The purpose of the present proposal was to investigate the predictive properties of markers in exhaled breath to predict an asthma exacerbation. In addition, the reliability of home monitor assessment...
Eligibility Criteria
Inclusion
- already known with a diagnosis of asthma during at least 6 months
- age between 6 and 17 years
- reversibility to a bronchodilator (increase in FEV1 \> 9% of predicted value and/or
- bronchial hyperresponsiveness to histamine \< 8 mg/ml.
Exclusion
- cardiac abnormalities
- mental retardation, congenital abnormalities or existence of a syndrome
- active smoking
- no technical satisfactory performance of measurements
- no phone line or internet assess available at home.
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT01239238
Start Date
November 1 2010
End Date
March 1 2013
Last Update
November 15 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Hospital
Maastricht, Netherlands, 6202 AZ
2
Orbis Medical Centre
Sittard, Netherlands